Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders  by Diettrich, Ole et al.
Application of magnetic chromatography to the isolation of lysosomes
from ¢broblasts of patients with lysosomal storage disorders
Ole Diettricha;*, Kevin Millsa, Andrew W. Johnsona, Andrej Hasilikb, Bryan G. Winchestera
aInstitute of Child Health, 30 Guilford Street, London WC1 N1EH, UK
bInstitut fuºr physiologische Chemie, Karl-von-Frisch-Str. 1, 35043 Marburg, Germany
Received 18 November 1998
Abstract A method for the purification of lysosomes from
fibroblasts has been developed which uses endocytosis of
superparamagnetic colloidal iron dextran particles followed by
separation of the iron-containing lysosomes in a magnetic field.
This permitted isolation of lysosomes from fibroblasts from
patients with infantile sialic acid storage disorder and other
lysosomal storage diseases in which a shift in lysosomal density
induced by the storage material prevents purification by
centrifugation in a Percoll gradient. The magnetic lysosomes
isolated from these cells are very similar to those from normal
cells as judged by lysosomal marker enzyme activity and 2D-
PAGE analysis of the enriched proteins.
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1. Introduction
It is very important for proteome research and the diagno-
sis of speci¢c protein defects to be able to purify organelles
from cultured cells to obtain preparations of organelle-asso-
ciated proteins. These proteins can then be identi¢ed by
searching databases, checked for aberrations or, if still un-
identi¢ed, sequenced and cloned. In the case of the lysosome
there are several inherited disorders where the speci¢c protein
defect has not been identi¢ed. This is especially true for lyso-
somal membrane proteins about which very little is known
apart from their enzymic or transport functions.
Lysosomes can normally be isolated from many di¡erent
types of cells by centrifugation in density gradients. In the
case of infantile sialic acid storage disorder (ISSD) though,
it has been observed by others [1,2] and ourselves that the
density of the lysosomal compartment is decreased by the
stored material so that puri¢cation by gradient centrifugation
is impossible. The same is true for cells from patients with K-
mannosidosis (unpublished data), Batten’s disease [3], Farber
disease [4] and presumably a number of other lysosomal stor-
age diseases. Therefore we sought a method which would
allow puri¢cation of lysosomes which is independent of their
buoyant density and their morphology, both of which are
likely to be altered in lysosomal storage diseases. Even if
gradient centrifugation could be modi¢ed to produce an en-
richment of the lysosomes with an altered density, the con-
taminating proteins co-puri¢ed under the new conditions
would be di¡erent from those obtained under standard con-
ditions and would further complicate the identi¢cation of spe-
ci¢c lysosomal proteins by 2D-PAGE. Rodriguez-Paris et al.
[5] have used endocytosis of iron dextran (FeDex) followed by
magnetic chromatography to isolate phagolysosomes from
Dictyostelium. In this paper we show that lysosomes with
decreased density due to the accumulation of storage material
can be isolated e⁄ciently from cultured ¢broblasts by mag-
netic chromatography after endocytosis of FeDex.
2. Material and methods
2.1. Chemicals
Protease inhibitors were from Boehringer Mannheim except for
benzyloxycarbonyl-L-phenylalanine-L-phenylalanine-diazomethyl ke-
tone (ZFF) which was generously provided by Heidrun Kirschke
(Halle-Wittenberg, Germany). Millex-GV Filters (0.22 Wm) were
from Millipore S.A. (Molsheim, France). Nutrient mixture Ham’s
F-10, trypsin EDTA, Dulbecco’s PBS and penicillin/streptomycin
(5000 IU/ml, 5 mg/ml) solutions were from Gibco BRL/Life Technol-
ogies (Paisley, UK). FCS was from Imperial Laboratories (Andover,
UK). 4-Methylumbelliferyl substrates were purchased from Melford
Laboratories Ltd. (Ipswich, UK). MiniMACS separation columns
were obtained from Miltenyi Biotec GmbH (Bergisch Gladbach, Ger-
many). Immobiline dry strips were from Pharmacia Biotech (St. Al-
bans, UK). All other chemicals were from Sigma (Poole, UK).
2.2. Cell lines and cell culture
Human skin ¢broblasts were derived from two normal individuals,
three patients with ISSD, one patient with nephropathic cystinosis
and one with late-infantile neuronal ceroid lipofuscinosis (variant
CLN6). Cells were cultured in Ham’s F-10 medium with 10% FCS
and 1% PenStrep in a 5% CO2 atmosphere.
2.3. Preparation of colloidal iron dextran particles
Superparamagnetic particles were prepared as described by Rodri-
guez-Paris et al. [5] : 10 ml of 1.2 M FeCl2 and 10 ml of 1.8 M FeCl3
were mixed in a 500 ml beaker. The solution was constantly agitated
(no magnetic stirrer) while 10 ml of 30% NH3 was added. Agitation
continued until the suspension was freely £owing again. Next, 100 ml
of 5% NH3 was added and the beaker placed on top of a magnet until
the precipitate gathered at the bottom. With the magnet still in place
the supernatant was decanted. After removal of the magnet the sedi-
ment was resuspended in 100 ml H2O and then collected again on the
magnet. This washing step was repeated once more. The ¢nal sedi-
ment was resuspended in 80 ml of 0.3 M HCl and stirred with a
magnetic stirring bar for 30 min. After this time 4 g of dextran T40
was added and stirring continued for at least 30 min. This suspension
was dialyzed for 2 days at 4‡C against 8 l of deionized water with
three changes of the dialysis bath. Dialysis can be monitored by
checking the pH of the dialysis bath prior to each change. Large
aggregates were removed by centrifugation for 10 min at 15 000 rpm
(Sorvall SS-34). The supernatant was removed, sterile ¢ltered at 0.22
Wm to yield FeDex particles. This solution could be stored at 4‡C for
up to 2 months and had a dry weight of 53 mg/ml.
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2.4. Loading of ¢broblasts in culture with FeDex
The FeDex suspension (13.5 ml) was mixed with 20 ml of culture
medium and evaporated to a total of 20 ml in a Speed Vac evapo-
rator. The FeDex-containing medium was immediately sterile ¢ltered
at 0.22 Wm and added to a con£uent layer of ¢broblasts in a 175 cm2
£ask. Loading was carried out for 9 h or the time indicated at 37‡C
after which the cells were washed once with PBS and left with fresh
medium overnight.
2.5. Harvesting of cells
The cells were detached in 3 ml of trypsin-EDTA solution for 15^20
min at 37‡C, after which 5 ml of MEM medium containing 10% FCS
was added and the suspension transferred to a 15 ml conical tube. The
£ask was rinsed with 6 ml of Dulbecco’s PBS (0.1 g CaCl2/l) which
was also added to the suspension. The cells were centrifuged for 10
min at 600Ug at 4‡C. From this point onwards all steps were per-
formed in an ice/water bath or in the cold room. The supernatant was
removed and the cells were washed once with 6 ml of 250 mM sucrose
in 4 mM imidazole/HCl bu¡er, pH 7.4 (bu¡er A).
The cell pellets were brought to a volume of 600 Wl with bu¡er A*
(bu¡er A containing 5 mM iodoacetamide, 1 Wg/ml leupeptin, 1 Wg/ml
pepstatin, 1 Wg/ml ZFF and 500 Wg/ml Pefabloc [4-(2-aminoethyl)-
benzenesulfonyl £uoride]). Cells were broken up in four 150 Wl ali-
quots by 8 strokes in a ‘0.1 ml’ Potter-Elvehjem homogenizer. The
homogenizer was rinsed with 150 Wl of bu¡er A* which was added to
the homogenate. The homogenate was centrifuged at 600Ug for 5 min
and the postnuclear supernatant (PNS) removed.
The Ca2/Mg2/EDTA content of the above solutions resulted in
optimal recovery of enriched lysosomes. A higher Ca2 concentration
will reduce the recovery in the PNS while EDTA will prevent binding
of vesicles to the magnetic column.
2.6. Magnetic a⁄nity chromatography
MiniMACS columns, which have been developed for cell separation
by magnetic chromatography, were equilibrated with bu¡er A. The
PNS was split into three aliquots (200 Wl) which were applied to three
columns in parallel with the magnet attached and unbound material
was collected by gravity. The column was washed with 1.5 ml of TBS
(150 mM NaCl; 5 mM Tris-HCl pH 7.4) before the bound material
was eluted in two successive steps. First 100 Wl of hypotonic bu¡er B
(5 mM Tris-HCl pH 7.4 with the same protease inhibitor concentra-
tions as in bu¡er A*) were added and held on the column for 15 min
to lyse the lysosomes osmotically. The soluble lysosomal proteins were
eluted with another 100 Wl of bu¡er B whilst the lysosomal ‘ghosts’
were retained on the column by the FeDex. These two eluates were
combined to form the luminal protein fraction (fraction 1). The lyso-
somal membrane proteins were eluted by removal of the magnet and
addition of 100 Wl of bu¡er B containing 0.5% (v/v) Triton X-100.
After incubation for 15 min another 100 Wl aliquot of the same solu-
tion was applied. These two eluates were combined to form the
lysosomal membrane fraction (fraction 2). All samples were frozen
as 200 Wl aliquots in liquid nitrogen and stored at 370‡C.
2.7. Enzyme assays
L-Hexosaminidase [6], L-galactosidase [7] and K-fucosidase [8] were
assayed as described previously. L-Glucosidase was assayed as fol-
lows. The sample was diluted in 2 mM Tris-HCl, pH 7.4, containing
150 mM NaCl and 0.1% HSA. To 50 Wl of this was added 50 Wl of the
following substrate solution: 10 mM 4-methylumbelliferyl-L-D-gluco-
pyranoside; 50 mM sodium taurocholate; 0.2%(v/v) Triton X-100;
0.1% HSA; 40 mM CaCl2 in McIlvaine’s citric acid-sodium phos-
phate bu¡er, pH 5.4. After incubation at 37‡C for 60 min the reaction
was stopped with 1 ml of 0.25 M glycine/NaOH, pH 10.4. The re-
leased 4-methylumbelliferone was measured at 450 nm using an ex-
citation wavelength of 365 nm. Citrate synthase was determined as
published [9]. Protein was determined with the Bio-Rad Protein assay
(Bio-Rad, Munich, Germany) using bovine IgG as a standard protein.
2.8. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE)
The separation of proteins by 2D-PAGE was carried out as previ-
ously reported [10] with the following changes. Immobiline dry strips
with a pH range of 4^7 and a length of 180 mm were used for the ¢rst
dimension. Focusing was carried out at 24‡C for approximately 70
kVh at a maximum voltage of 3500 V. The gels were silver-stained
following the protocol of Jungblut and Seifert [11].
3. Results
Con£uent ¢broblasts from normal controls and patients
with lysosomal storage disease were loaded with FeDex for
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Table 1
Enzyme activities in lysosomes puri¢ed with FeDex (n = 4)
Fraction Speci¢c activity (nmol/min/mg) Enrichment relative to homogenate Recovery % of homogenate
L-Hexosaminidase
Homogenate 210 þ 27 1.0 100
PNS 198 þ 64 0.93 þ 0.18 52 þ 13
Fraction 1 2494 þ 758 12 þ 4 4.8 þ 1.6
Fraction 2 1902 þ 784 8.9 þ 2.5 19 þ 4
L-Glucosidase
Homogenate 6.5 þ 0.5 1.0 100
PNS 5.7 þ 1.5 0.87 þ 0.15 48 þ 11
Fraction 1 17 þ 4 2.7 þ 0.9 1.0 þ 0.2
Fraction 2 86 þ 37 13 þ 5 27 þ 6
K-Fucosidase
Homogenate 0.87 þ 0.51 1.0 100
PNS 0.75 þ 0.34 0.93 þ 0.19 52 þ 14
Fraction 1 30 þ 22 31 þ 8 12 þ 2
Fraction 2 4.1 þ 2.0 5.0 þ 1.2 11 þ 2
L-Galactosidase
Homogenate 16 þ 1 1.0 100
PNS 15 þ 3 0.91 þ 0.15 51 þ 11
Fraction 1 577 þ 128 36 þ 6 14 þ 3
Fraction 2 95 þ 31 5.9 þ 1.7 12 þ 2
Citrate synthase
Homogenate 136 þ 28 1.0 100
PNS 117 þ 38 0.85 þ 0.13 48 þ 9
Fraction 1 (none detected) 6 0.5 6 0.2
Fraction 2 47 þ 25 0.33 þ 0.14 0.74 þ 0.34
Lysosomes were isolated from two normal ¢broblast lines by uptake of FeDex followed by magnetic chromatography using the two-step elution
protocol. Fraction 1 is the material eluted under hypotonic conditions with the magnet still switched on. Fraction 2 is material eluted with a
detergent-containing eluent with the magnet removed. Enzyme activities and protein content were assayed in the homogenate, PNS and the two
fractions. Citrate synthase activities in fraction 1 were below the detection limit of the assay. Values are means þ S.D.
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di¡erent times and then incubated with fresh normal medium
overnight. The appearance of the cells was monitored by light
microscopy and no morphological changes were found for up
to 12 h contact with the FeDex. A loading time of 9 h was
adopted for all subsequent preparations. The cells were har-
vested, homogenized and the PNS applied to the MiniMACS
column. It was observed that after removing the magnet from
the column, the recovery of presumably intact lysosomes by
elution with isotonic bu¡er was only minimal and that the
application of hypotonic or detergent-containing bu¡ers was
necessary to obtain reasonable yields. Glombitza et al. [12]
had seen similar results.
Therefore a two-step elution protocol was devised: release
of soluble luminal proteins by lysis of bound lysosomes with
hypotonic bu¡er (fraction 1) followed by elution of bound
material by detergent-containing bu¡er after removal of the
magnet (fraction 2). The results for the duplicate analysis of
two normal ¢broblast lines are given in Table 1. L-Hexosami-
nidase, K-fucosidase and L-galactosidase, which are soluble
luminal enzymes, were eluted in both of the fractions but
the enrichment was always much greater in fraction 1. In
contrast, L-glucosidase, which is a membrane-associated en-
zyme, was found almost exclusively in the second fraction.
Mitochondrial contamination as assessed by citrate synthase
activity was not detected in fraction 1 and less than 1% was
recovered in fraction 2.
This shows that the procedure e⁄ciently separates lyso-
somes from mitochondria and that the luminal and membrane
proteins of the lysosome can be selectively eluted from the
magnetic column.
This technique was then applied to the PNS of ¢broblasts
from patients with ISSD and other lysosomal storage disor-
ders (Table 2). Allowing for the variation in activities within
each ¢broblast type, there is no apparent di¡erence in the
e⁄ciency of the puri¢cation of lysosomes between the control
lines and any of the storage ¢broblast lines, indicating that the
endogenous storage material does not a¡ect the separation.
To illustrate further the similarity of the lysosomal prepa-
rations from normal cells and those from a storage disease,
the enriched fractions 1 and 2 from control and ISSD lines
were analyzed by 2D-PAGE (Fig. 1). From our previous ex-
perience the group of spots designated A are very likely to be
cathepsin D. The protein designated B was con¢rmed to be
actin, which is known to interact with and bind to lysosomes
[13^15]. The spots marked by arrowheads had also been iden-
ti¢ed previously as lysosomal [10]. Three were present in both
fractions albeit relatively more abundantly in the luminal frac-
tion while the largest (V40 kDa) was found exclusively in
fraction 2, suggesting it was membrane-associated.
4. Discussion
Our results show that lysosomes from ¢broblasts from pa-
tients with a range of lysosomal storage diseases, in which the
accumulation of storage material has altered the density of the
lysosomes and prevents their separation from other organelles
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Fig. 1. 2D-PAGE with silver staining of lysosomal preparations from normal ¢broblasts (top panels) and ¢broblasts from patients with ISSD
(bottom panels). Fractions 1 and 2 were prepared as described in the legend to Table 1. Spots A have been identi¢ed as actin. Spots B are
thought to be cathepsin D. Arrowheads point to proteins previously shown to be lysosomal proteins.
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by density centrifugation, can be isolated by magnetic chro-
matography. The simplicity of the protocol also makes it con-
venient for the isolation of lysosomes from normal ¢broblasts.
It is possible that the method might not be applicable to
¢broblasts from some storage diseases because the lysosomes
cannot tolerate the additional load of FeDex. Subcon£uent
ISSD cells were seen to show some damage morphologically
after 12 h of loading. With sensitive ¢broblasts the pulse time
can be decreased to 3 h with a decrease in recovery of lyso-
somes of only approximately 5%.
It is assumed that the method relies on the non-speci¢c
uptake of FeDex (37 mg iron dextran per ml medium) by
£uid phase endocytosis and its transfer by the default endo-
cytotic pathway to highly acidi¢ed secondary lysosomes, in a
similar manner to dextran alone [16]. In the original work on
Dictyostelium phagolysosomes by Rodriguez-Paris et al. [5] a
much lower concentration of FeDex (2 mg/ml) and only 15
min exposure time to the FeDex-containing medium could be
used because of the high pinocytotic activity of this slime
mold. Glombitza et al. [12] used an endocytosis time of 24
h and unknown FeDex concentration for the isolation of ly-
sosomes from keratinocytes. Becich and Baenziger [17] used
FeDex (0.2 mg/ml) covalently conjugated with Gal-BSA or
asialofetuin to isolate endosomes and lysosomes from
HepG2 cells by exploiting the asialoglycoprotein receptor ex-
pressed on this cell type. They only monitored acid L-galacto-
sidase as a lysosomal marker and found a recovery of 8^9% of
the activity relative to the PNS with a 9-fold enrichment. In
contrast, in the present study recoveries relative to the PNS of
29% in the ¢rst fraction and 25% in the second were obtained
with enrichments of 40- and 6-fold, respectively. For ¢bro-
blasts, the resulting purity of the lysosomes is similar to that
achieved by Percoll density gradient centrifugation [18]. Gen-
erally, the maximum achievable enrichment of lysosomes will
depend on the abundance of lysosomes in the starting materi-
al.
Using the two-step elution protocol soluble lysosomal en-
zymes were eluted in both fractions but the enrichment was
always greater in fraction 1, in which less than 1% of the
membrane-associated L-glucosidase was recovered. Associa-
tion with the colloidal gel may be responsible for the soluble
lysosomal enzymes found in fraction 2.
The 2D-PAGE patterns of lysosomal proteins were very
similar in the corresponding eluted fractions for normal and
ISSD cells. The storage material did not lead to major second-
ary changes in the molecular weight and isoelectric point of
proteins.
This method allows lysosomes from patients with a wide
range of lysosomal storage diseases to be puri¢ed and sub-
jected to biochemical analysis. One application is the compar-
ison of the protein patterns obtained by 2D-PAGE for lyso-
somes from controls and patients to identify underlying
protein defects. This procedure has already revealed candidate
proteins for the lysosomal sialic acid transporter, that is de-
fective in ISSD, indicating the value of the procedure.
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Table 2
Recovery and enrichment of marker enzymes in lysosomes prepared
from PNS from di¡erent ¢broblast lines
Enrichment relative to PNS Total recoverya
(% of PNS)
Fraction 1 Fraction 2
Normal (n = 4)
L-Hex 13 þ 5 9.5 þ 1.0 46 þ 4
L-Gluc 3.2 þ 1.4 15 þ 3 59 þ 2
ISSD (n = 3)
L-Hex 14 þ 4 6.0 þ 1.0 22 þ 5
L-Gluc 1.4 þ 1.2 16 þ 6 32 þ 7
Cystinosis (n = 1)
L-Hex 13 7.0 37
L-Gluc 1.2 16 44
NCL6 (n = 1)
L-Hex 10.5 7.9 43
L-Gluc 0.9 19 58
Lysosomal fractions from two normal ¢broblast lines (same experi-
ment as Table 1), three ISSD lines and one line each of patients with
nephropathic cystinosis and late infantile neuronal ceroid lipofuscino-
sis (CLN6) were prepared as described in the legend to Table 1. The
PNS and the two eluate fractions were assayed for L-hexosaminidase
(L-Hex), L-glucosidase (L-Gluc) and protein content.
aRatio of the sum of total enzyme activities in fractions 1 and 2 over
the total activity in the PNS. For normal controls and ISSD cells
values are means þ S.D.
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